Related Experiment Video
Updated: Jun 14, 2025
04:30
Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
Published on: March 8, 2024
649
Sugammadex vs Neostigmine, a Comparison in Reversing Neuromuscular Blockade: A Narrative Review
Shafaque Maqusood1, Amol Bele1, Neeta Verma1
1Anaesthesiology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus
|August 29, 2024
Summary
Sugammadex offers faster and more reliable reversal of neuromuscular blocking agents than neostigmine. This review highlights sugammadex
Area of Science:
- Anesthesiology and Pharmacology
- Surgical Procedures and Patient Safety
Background:
- Neuromuscular blocking agents (NMBA) are increasingly used in minimally invasive surgery.
- Residual neuromuscular blockade poses risks including respiratory insufficiency and aspiration.
- Pharmacologic reversal agents like sugammadex and neostigmine are crucial for safe extubation.
Purpose of the Study:
- To compare the efficacy and safety of sugammadex versus neostigmine for reversing neuromuscular blockade.
- To assess the clinical utility of sugammadex in modern surgical practice.
Main Methods:
- Comprehensive review of existing literature comparing sugammadex and neostigmine.
- Analysis of studies focusing on reversal speed, efficacy, and safety profiles.
- Evaluation of train-of-four (TOF) ratios achieved with both agents.
Main Results:
- Sugammadex demonstrates significantly faster and more predictable reversal of neuromuscular blockade.
- Sugammadex reliably achieves desired train-of-four (TOF) ratios across various surgical settings.
- Neostigmine shows limitations in efficacy and speed, despite widespread use and lower cost.
Conclusions:
- Sugammadex presents considerable advantages over neostigmine in reversing neuromuscular blockade.
- The speed, predictability, and safety profile of sugammadex make it a superior option.
- Clinical adoption of sugammadex requires careful consideration of its benefits and drawbacks.
Related Concept Videos
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
401
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
401
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.7K
01:28Depolarizing Blockers: Mechanism of Action
1.5K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.5K
01:19Depolarizing Blockers: Pharmocokinetics
315
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
315
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
437
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
437
01:21Skeletal Muscle Relaxants: Adverse Effects
348
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
348